These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17671675)

  • 1. Immunohistochemical detection of the lymphatic marker podoplanin in diverse types of human cancer cells using a novel antibody.
    Kono T; Shimoda M; Takahashi M; Matsumoto K; Yoshimoto T; Mizutani M; Tabata C; Okoshi K; Wada H; Kubo H
    Int J Oncol; 2007 Sep; 31(3):501-8. PubMed ID: 17671675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of monoclonal antibody LpMab-3 recognizing sialylated glycopeptide of podoplanin.
    Oki H; Ogasawara S; Kaneko MK; Takagi M; Yamauchi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Feb; 34(1):44-50. PubMed ID: 25723283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
    Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
    Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma].
    Breiteneder-Geleff S; Soleiman A; Horvat R; Amann G; Kowalski H; Kerjaschki D
    Verh Dtsch Ges Pathol; 1999; 83():270-5. PubMed ID: 10714221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10.
    Pancino GF; Le Doussal V; Mortada MH; Berthon P; Osinaga E; Calvo F; Roseto A
    Cancer Res; 1989 Dec; 49(24 Pt 1):7078-85. PubMed ID: 2555058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of podoplanin in tumor progression and metastasis.
    Raica M; Cimpean AM; Ribatti D
    Anticancer Res; 2008; 28(5B):2997-3006. PubMed ID: 19031946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.
    Schacht V; Dadras SS; Johnson LA; Jackson DG; Hong YK; Detmar M
    Am J Pathol; 2005 Mar; 166(3):913-21. PubMed ID: 15743802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of the novel platelet activation receptor CLEC-2 and Its pathological and physiological roles].
    Suzuki Inoue K; Inoue O; Ozaki Y
    Rinsho Byori; 2010 Dec; 58(12):1193-202. PubMed ID: 21348239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
    Ordóñez NG
    Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
    Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K
    Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podoplanin: a novel diagnostic immunohistochemical marker.
    Ordóñez NG
    Adv Anat Pathol; 2006 Mar; 13(2):83-8. PubMed ID: 16670463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma.
    Mishima K; Kato Y; Kaneko MK; Nakazawa Y; Kunita A; Fujita N; Tsuruo T; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 Jun; 111(6):563-8. PubMed ID: 16718353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells.
    Kaneko M; Kato Y; Kunita A; Fujita N; Tsuruo T; Osawa M
    J Biol Chem; 2004 Sep; 279(37):38838-43. PubMed ID: 15231832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic vessel density and lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Horvath LG; Sutherland RL; Williams ED
    Prostate; 2005 Nov; 65(3):222-30. PubMed ID: 15948136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel targeting therapy of malignant mesothelioma using anti-podoplanin antibody.
    Abe S; Morita Y; Kaneko MK; Hanibuchi M; Tsujimoto Y; Goto H; Kakiuchi S; Aono Y; Huang J; Sato S; Kishuku M; Taniguchi Y; Azuma M; Kawazoe K; Sekido Y; Yano S; Akiyama S; Sone S; Minakuchi K; Kato Y; Nishioka Y
    J Immunol; 2013 Jun; 190(12):6239-49. PubMed ID: 23690472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.
    Rahadiani N; Ikeda J; Makino T; Tian T; Qiu Y; Mamat S; Wang Y; Doki Y; Aozasa K; Morii E
    Ann Surg Oncol; 2010 May; 17(5):1311-23. PubMed ID: 20066519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatics and D2-40/podoplanin expression in gastrointestinal stromal tumours of the stomach with and without lymph node metastasis: an immunohistochemical study with special reference to the Carney triad.
    Agaimy A; Carney JA
    J Clin Pathol; 2010 Mar; 63(3):229-34. PubMed ID: 20203222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain.
    Kaneko MK; Abe S; Ogasawara S; Fujii Y; Yamada S; Murata T; Uchida H; Tahara H; Nishioka Y; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):25-29. PubMed ID: 28157429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.